SITC 2023 Election Voting for the 2023 SITC Election took place Tuesday, May 2–Tuesday, May 16. SITC members voted to select the society’s next Secretary/Treasurer and three At-Large Directors. Secretary/Treasurer At-Large Directors Join/Renew Membership SITC Congratulates 2023...
Sept. 28–29, 2023 in Chicago or Aug. 9–10, 2023 Virtual The Women in Cancer Immunotherapy Network (WIN) is a SITC initiative seeking to promote and elevate women in the cancer immunotherapy field. Applications for the WIN Leadership Institute were due on April 11, 2023, at 5 p.m. PST and are now...
Cancer Immunotherapy Winter School Jan. 30–Feb. 2, 2024 | Austin, TX and Virtual Tailored to early-to-mid career scientists and clinicians in the field of cancer immunotherapy working in academic, clinical, industry and government settings, this hybrid program provides the best in cancer...
On October 28, 2022, leading experts from the SITC Nonmelanoma Skin Cancer Immunotherapy Guideline Expert Panel presented "Case Studies in Immunotherapy for the Treatment of Nonmelanoma Skin Cancer – SITC CPG Webinar." This high-level webinar included case studies that illustrated execution of...
2 attachments
On October 3, 2022, leading experts from the SITC Nonmelanoma Skin Cancer Immunotherapy Guideline Expert Panel presented "Practical Management Pearls for Immunotherapy for the Treatment of Nonmelanoma Skin Cancer — SITC CPG Webinar." This high-level webinar was designed to teach attendees how...
Nonmelanoma skin cancers (NMSCs) are some of the most commonly diagnosed malignancies. In general, early-stage NMSCs have favorable outcomes; however, a small subset of patients develop resistant, advanced, or metastatic disease, or aggressive subtypes that are more challenging to treat...
This is the library for the Enduring Materials from the Targets for Cancer IO: A Deep Dive, iPSC derived cell therapies webinar that was conducted on September 26, 2022 . Moderators: Kalle Malmberg, MD, PhD - Oslo University Hospital Jeffrey S. Miller, MD - University of...
3 attachments
Immunotherapy has transformed lung cancer care in recent years. In addition to providing durable responses and prolonged survival outcomes for a subset of patients with heavily pretreated non-small cell lung cancer (NSCLC), immune checkpoint inhibitors (ICIs)— either as monotherapy or in...
On August 23, 2022, leading experts from the SITC Lung Cancer and Mesothelioma Immunotherapy Guideline Expert Panel presented "Practical Management Pearls for Immunotherapy for the Treatment of Lung Cancer and Mesothelioma — SITC CPG Webinar." This high-level webinar was designed to teach...
Advances in Cancer Immunotherapy™ is a CME- and CE-certified program for clinical oncologists, registered nurses, pharmacists and others involved in treating cancer patients with immunotherapy to learn basic immunology principles and the mechanisms and clinical applications of immunotherapy. ...
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us